BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2322501)

  • 21. Estimating the economic costs of skin cancer in New South Wales, Australia.
    Doran CM; Ling R; Byrnes J; Crane M; Searles A; Perez D; Shakeshaft A
    BMC Public Health; 2015 Sep; 15():952. PubMed ID: 26400024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional variations of basal cell carcinoma incidence in the U.K. using The Health Improvement Network database (2004-10).
    Musah A; Gibson JE; Leonardi-Bee J; Cave MR; Ander EL; Bath-Hextall F
    Br J Dermatol; 2013 Nov; 169(5):1093-9. PubMed ID: 23701520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of basal cell carcinomas and squamous cell carcinomas in a Department of Dermatology: a 5 year review.
    Andrade P; Brites MM; Vieira R; Mariano A; Reis JP; Tellechea O; Figueiredo A
    An Bras Dermatol; 2012; 87(2):212-9. PubMed ID: 22570024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow.
    Lucke TW; Hole DJ; Mackie RM
    Br J Dermatol; 1997 Nov; 137(5):761-3. PubMed ID: 9415237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of skin tumors: data from the cutaneous cancer registry in Trentino, Italy.
    Boi S; Cristofolini M; Micciolo R; Polla E; Dalla Palma P
    J Cutan Med Surg; 2003; 7(4):300-5. PubMed ID: 12879331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11.
    Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G
    Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UK.
    Pearce MS; Parker L; Cotterill SJ; Gordon PM; Craft AW
    Melanoma Res; 2003 Aug; 13(4):421-6. PubMed ID: 12883370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of skin cancer.
    Diepgen TL; Mahler V
    Br J Dermatol; 2002 Apr; 146 Suppl 61():1-6. PubMed ID: 11966724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changing face of skin cancer in Australia.
    Czarnecki D; Meehan C; O'Brien T; Leahy S; Nash C
    Int J Dermatol; 1991 Oct; 30(10):715-7. PubMed ID: 1955227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005.
    Holterhues C; Vries Ed; Louwman MW; Koljenović S; Nijsten T
    J Invest Dermatol; 2010 Jul; 130(7):1807-12. PubMed ID: 20336085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence of non-melanocytic skin cancers in an Australian population: results of a five-year prospective study.
    Marks R; Jolley D; Dorevitch AP; Selwood TS
    Med J Aust; 1989 May; 150(9):475-8. PubMed ID: 2786135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work.
    Beral V; Robinson N
    Br J Cancer; 1981 Dec; 44(6):886-91. PubMed ID: 7326198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonmelanoma skin cancer in the United States: incidence.
    Miller DL; Weinstock MA
    J Am Acad Dermatol; 1994 May; 30(5 Pt 1):774-8. PubMed ID: 8176018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
    van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
    J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictions of skin cancer incidence in the Netherlands up to 2015.
    de Vries E; van de Poll-Franse LV; Louwman WJ; de Gruijl FR; Coebergh JW
    Br J Dermatol; 2005 Mar; 152(3):481-8. PubMed ID: 15787817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant melanoma in West Glamorgan--increasing incidence and improving prognosis, 1986-88.
    Roberts DL
    Clin Exp Dermatol; 1990 Nov; 15(6):406-9. PubMed ID: 2279336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of nonmelanoma skin cancer in New Hampshire and Vermont.
    Serrano H; Scotto J; Shornick G; Fears TR; Greenberg ER
    J Am Acad Dermatol; 1991 Apr; 24(4):574-9. PubMed ID: 2033134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.